{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:11:10Z","timestamp":1778591470235,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["SBAG-222S063"],"award-info":[{"award-number":["SBAG-222S063"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003356","name":"Gazi \u00dcniversitesi","doi-asserted-by":"publisher","award":["TCD-2021-6982"],"award-info":[{"award-number":["TCD-2021-6982"]}],"id":[{"id":"10.13039\/501100003356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.urolonc.2026.111097","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:46:54Z","timestamp":1775598414000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repression of Septin9 inhibits the oncogenic phenotype of bladder cancer"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-943X","authenticated-orcid":false,"given":"Nuray","family":"Varol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-9387","authenticated-orcid":false,"given":"Nevin","family":"Belder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5450-5168","authenticated-orcid":false,"given":"Serhat","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1443-872X","authenticated-orcid":false,"given":"Seyma Gul","family":"Durgut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3727-3662","authenticated-orcid":false,"given":"Handan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1219-5082","authenticated-orcid":false,"given":"Fazli","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2573-3927","authenticated-orcid":false,"given":"Sinan","family":"Sozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.urolonc.2026.111097_bib0001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111097_bib0002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/JU.0000000000001380","article-title":"Rates and patterns of recurrences and survival outcomes after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium","volume":"205","author":"Elsayed","year":"2021","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111097_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0391560319899011","article-title":"Bladder cancer genomics","volume":"87","author":"Siracusano","year":"2020","journal-title":"Urologia"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111097_bib0004","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/bcr2924","article-title":"Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression","volume":"13","author":"Connolly","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.urolonc.2026.111097_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.762817","article-title":"Understanding the complex milieu of epithelial-mesenchymal transition in cancer metastasis: new insight into the roles of transcription factors","volume":"11","author":"Imodoye","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111097_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12964-021-00713-2","article-title":"The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems","volume":"19","author":"Leggett","year":"2021","journal-title":"Cell Commun Signal"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111097_bib0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrm3284","article-title":"Septins: the fourth component of the cytoskeleton","volume":"13","author":"Mostowy","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.urolonc.2026.111097_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109768","article-title":"Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-\u03b2-induced epithelial-mesenchymal transition (EMT)","volume":"125","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111097_bib0009","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4251\/wjgo.v12.i6.619","article-title":"Structure and function of Septin 9 and its role in human malignant tumors","volume":"12","author":"Sun","year":"2020","journal-title":"World J Gastrointest Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2026.111097_bib0010","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41419-019-1947-9","article-title":"SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA\/FAK signaling pathway regulation","volume":"10","author":"Zeng","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111097_bib0011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41588-024-02030-z","article-title":"Comprehensive genomic characterization of early-stage bladder cancer","volume":"57","author":"Prip","year":"2025","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111097_bib0012","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00432-018-02829-4","article-title":"A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer","volume":"145","author":"Stubendorff","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.111097_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211047352","article-title":"Metastatic Urothelial cancer: a rapidly changing treatment landscape","volume":"13","author":"Stecca","year":"2021","journal-title":"Ther Adv Med Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.111097_bib0014","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3390\/cancers13081882","article-title":"Cytoskeletal dynamics in epithelial-mesenchymal transition: insights into therapeutic targets for cancer metastasis","volume":"13","author":"Datta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2026.111097_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.taap.2016.12.002","article-title":"Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis","volume":"315","author":"Wu","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"issue":"30","key":"10.1016\/j.urolonc.2026.111097_bib0016","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1038\/s41388-019-0844-0","article-title":"Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions","volume":"38","author":"Marcus","year":"2019","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.urolonc.2026.111097_bib0017","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/biom14091194","article-title":"SEPT9_i1 and septin dynamics in oncogenesis and cancer treatment","volume":"14","author":"J\u0119drzejczak","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111097_bib0018","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1186\/s12885-024-12877-4","article-title":"SEPT9: from pan-cancer to lung squamous cell carcinoma","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111097_bib0019","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41419-019-1318-6","article-title":"Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel","volume":"10","author":"Targa","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.urolonc.2026.111097_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1741-7015-9-133","article-title":"Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer","volume":"9","author":"Warren","year":"2011","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111097_bib0021","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13148-020-00833-5","article-title":"SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt\/\u03b2-catenin signaling pathway via miR92b-3p\/FZD10 in nasopharyngeal carcinoma cells","volume":"12","author":"Jiang","year":"2020","journal-title":"Clin Epigenetics"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111097_bib0022","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3892\/ol.2022.13580","article-title":"Potential of blood exosomal ENAH, SEPT9, EGF, MMP-9 and CXCL8 for the early screening of breast cancer","volume":"24","author":"Zhang","year":"2022","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111097_bib0023","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s12885-016-2748-5","article-title":"Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive\/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer","volume":"16","author":"Roperch","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2026.111097_bib0024","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/1471-2407-13-398","article-title":"Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island","volume":"13","author":"Wasserkort","year":"2013","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.urolonc.2026.111097_bib0025","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.21037\/tcr-20-1330","article-title":"Circulating methylated septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer","volume":"9","author":"Cao","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111097_bib0026","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13148-019-0719-9","article-title":"Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance","volume":"11","author":"Jiao","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111097_bib0027","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.canlet.2016.02.010","article-title":"Novel fusion transcripts in bladder cancer identified by RNA-seq","volume":"374","author":"Kekeeva","year":"2016","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111097_bib0028","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1083\/jcb.201405050","article-title":"Septins promote stress fiber-mediated maturation of focal adhesions and renal epithelial motility","volume":"207","author":"Dolat","year":"2014","journal-title":"J Cell Biol"},{"issue":"10","key":"10.1016\/j.urolonc.2026.111097_bib0029","first-page":"2369","article-title":"Septin 9 expression regulates \u201cdon\u2019t eat me\u201d signals and identifies an immune-epithelial class of intrahepatic cholangiocarcinoma","volume":"18","author":"Cai","year":"2024","journal-title":"Mol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111097_bib0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41419-018-0547-4","article-title":"Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells","volume":"9","author":"Xu","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.urolonc.2026.111097_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2024.104909","article-title":"Epithelial-mesenchymal transition associated markers in sarcomatoid transformation of clear cell renal cell carcinoma","volume":"138","author":"\u010cugura","year":"2024","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.urolonc.2026.111097_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.887693","article-title":"Identification of EMT-related genes and prognostic signature with significant implications on biological properties and oncology treatment of lower grade gliomas","volume":"10","author":"Wu","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.111097_bib0033","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.trecan.2025.04.004","article-title":"Tissue mechanics in tumor heterogeneity and aggression","volume":"11","author":"Finger","year":"2025","journal-title":"Trends Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926001080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926001080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:22:37Z","timestamp":1778588557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1078143926001080"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111097","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repression of Septin9 inhibits the oncogenic phenotype of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}